Mersana Therapeutics
MRSN
MRSN
42 hedge funds and large institutions have $302M invested in Mersana Therapeutics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
42
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.95M | |
| 2 | +$4.56M | |
| 3 | +$3.73M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.21M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.44M |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$2.85M | |
| 3 | -$1.75M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.51M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$878K |